GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Study Examines Barriers to Healthcare Access for Non-Communicable Disease Patients in India

by GOAI
Share To

A recent systematic review has examined healthcare utilization and health-seeking behavior among patients with non-communicable diseases (NCDs) in India. Conducted by researchers Siva, N., Samantaray, K.K., and Krishnapriya, K., the study highlights key factors influencing access to healthcare services in a country facing significant challenges related to NCD management. The research provides insights into the barriers and facilitators affecting how individuals seek medical care for conditions such as diabetes, cardiovascular diseases, cancer, and chronic respiratory illnesses.

The study explores a range of factors impacting healthcare utilization, including socioeconomic status, geographical location, cultural beliefs, and awareness levels about NCDs. It identifies disparities in access to healthcare between urban and rural populations and underscores the role of affordability in determining treatment options. Additionally, the review examines the availability of healthcare infrastructure and its influence on patient behavior. By analyzing these dynamics, the researchers aim to contribute to a better understanding of how systemic issues shape health outcomes for individuals living with non-communicable diseases in India.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 30, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top